Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 1/20 | 0.31 |
| ▸ | NEU4 | Q8WWR8 | 1/20 | 0.31 |
| ▸ | NEU3 | Q9UQ49 | 1/20 | 0.31 |
| ▸ | NEU2 | Q9Y3R4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31695091 | 0.92 | NANP (0.31) | NANPNEU4NEU3NEU2 | |
| SCHEMBL31695113 | 0.82 | — | — | |
| SCHEMBL31440877 | 0.80 | NANP (0.36) | NANPNEU4NEU3NEU2 | |
| SCHEMBL31695226 | 0.78 | — | — | |
| SCHEMBL30732541 | 0.77 | ABCB1 (0.33) | — | |
| SCHEMBL31695179 | 0.77 | ABCB1 (0.33) | — | |
| SCHEMBL31225519 | 0.77 | NEU4 (0.32) | NEU4NEU3NEU2 | |
| SCHEMBL31225606 | 0.77 | — | — | |
| SCHEMBL15090252 | 0.77 | NANP (0.48) | NANPNEU4NEU3NEU2 | |
| SCHEMBL16362518 | 0.77 | NANP (0.48) | NANPNEU4NEU3NEU2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
| EP-4536653-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | Eisai R&D Management Co., Ltd. (JP) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023239906-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | NEU1, NEU2, NEU4 | NANP 63/4885NEU4 3/4885NEU3 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.